Avidity Partners Management LP Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$4.6T
Holdings
85
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (85 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 4,062,000 | $337.1B | 7.30% | Call |
| 2 | ARGXARGENX SE | 625,000 | $236.8B | 5.13% | |
| 3 | UTHUNITED THERAPEUTICS CORP DEL | 785,500 | $218.4B | 4.73% | |
| 4 | NBIXNEUROCRINE BIOSCIENCES INC | 1,780,000 | $212.6B | 4.61% | |
| 5 | AKROAKERO THERAPEUTICS INC | 3,825,000 | $209.6B | 4.54% | |
| 6 | PRTAPROTHENA CORP PLC | 2,953,000 | $177.9B | 3.85% | |
| 7 | ARVNARVINAS INC | 4,950,000 | $169.3B | 3.67% | |
| 8 | BSXBOSTON SCIENTIFIC CORP | 3,256,700 | $150.7B | 3.26% | |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 5,861,000 | $149.2B | 3.23% | |
| 10 | RAREULTRAGENYX PHARMACEUTICAL IN | 2,990,000 | $138.5B | 3.00% | |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 1,055,000 | $136.7B | 2.96% | |
| 12 | MDGLMADRIGAL PHARMACEUTICALS INC | 430,000 | $124.8B | 2.70% | |
| 13 | UHSUNIVERSAL HLTH SVCS INC | 825,600 | $116.3B | 2.52% | |
| 14 | JAZZJAZZ PHARMACEUTICALS PLC | 727,541 | $115.9B | 2.51% | |
| 15 | ZNTLZENTALIS PHARMACEUTICALS INC | 5,150,000 | $103.7B | 2.25% | |
| 16 | ACHCACADIA HEALTHCARE COMPANY IN | 1,165,000 | $95.9B | 2.08% | |
| 17 | SGRYSURGERY PARTNERS INC | 3,112,000 | $86.7B | 1.88% | |
| 18 | DC4DEXCOM INC | 756,800 | $85.7B | 1.86% | |
| 19 | AZNASTRAZENECA PLC | 1,200,000 | $81.4B | 1.76% | |
| 20 | LLYLILLY ELI & CO | 217,000 | $79.4B | 1.72% | |
| 21 | PCVXVAXCYTE INC | 1,615,400 | $77.5B | 1.68% | |
| 22 | RNAAVIDITY BIOSCIENCES INC | 3,275,000 | $72.7B | 1.57% | |
| 23 | NTRANATERA INC | 1,798,900 | $72.3B | 1.57% | |
| 24 | IDYAIDEAYA BIOSCIENCES INC | 3,824,800 | $69.5B | 1.51% | |
| 25 | IMCRIMMUNOCORE HLDGS PLC | 1,154,000 | $65.9B | 1.43% | |
| 26 | ALTALTIMMUNE INC | 3,990,000 | $65.6B | 1.42% | |
| 27 | RVMDREVOLUTION MEDICINES INC | 2,475,000 | $59.0B | 1.28% | |
| 28 | KRTXKARUNA THERAPEUTICS INC | 299,000 | $58.8B | 1.27% | |
| 29 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,375,000 | $55.8B | 1.21% | |
| 30 | AXSMAXSOME THERAPEUTICS INC | 670,000 | $51.7B | 1.12% | |
| 31 | VRTXVERTEX PHARMACEUTICALS INC | 172,000 | $49.7B | 1.08% | |
| 32 | LEGNLEGEND BIOTECH CORP | 970,000 | $48.4B | 1.05% | |
| 33 | KZRKEZAR LIFE SCIENCES INC | 6,782,400 | $47.7B | 1.03% | |
| 34 | PLRXPLIANT THERAPEUTICS INC | 2,240,400 | $43.3B | 0.94% | |
| 35 | VTYXVENTYX BIOSCIENCES INC | 1,285,000 | $42.1B | 0.91% | |
| 36 | ICLRICON PLC | 215,000 | $41.8B | 0.90% | |
| 37 | DGXQUEST DIAGNOSTICS INC | 258,000 | $40.4B | 0.87% | |
| 38 | BUWABIO RAD LABS INC | 92,200 | $38.8B | 0.84% | |
| 39 | BLUBELLUS HEALTH INC NEW | 4,599,998 | $37.8B | 0.82% | |
| 40 | THCTENET HEALTHCARE CORP | 717,300 | $35.0B | 0.76% | |
| 41 | KPTIEURKARYOPHARM THERAPEUTICS INC | 9,633,911 | $32.8B | 0.71% | |
| 42 | BNTXBIONTECH SE | 215,400 | $32.4B | 0.70% | |
| 43 | VERVVERVE THERAPEUTICS INC | 1,565,000 | $30.3B | 0.66% | |
| 44 | RCKTROCKET PHARMACEUTICALS INC | 1,527,087 | $29.9B | 0.65% | |
| 45 | ITCIEURINTRA-CELLULAR THERAPIES INC | 504,000 | $26.7B | 0.58% | |
| 46 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,755,000 | $26.0B | 0.56% | |
| 47 | —PROMETHEUS BIOSCIENCES INC | 204,000 | $22.4B | 0.49% | |
| 48 | NTLAINTELLIA THERAPEUTICS INC | 638,200 | $22.3B | 0.48% | |
| 49 | VIRVIR BIOTECHNOLOGY INC | 850,000 | $21.5B | 0.47% | |
| 50 | PHATPHATHOM PHARMACEUTICALS INC | 1,900,000 | $21.3B | 0.46% | |
| 51 | BHVNBIOHAVEN LTD | 1,492,000 | $20.7B | 0.45% | |
| 52 | CYTKCYTOKINETICS INC | 420,700 | $19.3B | 0.42% | |
| 53 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,126,000 | $18.5B | 0.40% | |
| 54 | CRBUCARIBOU BIOSCIENCES INC | 2,882,600 | $18.1B | 0.39% | |
| 55 | OPHTEURIVERIC BIO INC | 838,407 | $18.0B | 0.39% | |
| 56 | —POINT BIOPHARMA GLOBAL INC | 2,432,400 | $17.7B | 0.38% | |
| 57 | NSTGEURNANOSTRING TECHNOLOGIES INC | 2,057,200 | $16.4B | 0.36% | |
| 58 | TWSTTWIST BIOSCIENCE CORP | 611,000 | $14.5B | 0.32% | |
| 59 | BCABBIOATLA INC | 1,260,000 | $10.4B | 0.23% | |
| 60 | CMPXCOMPASS THERAPEUTICS INC | 2,000,000 | $10.1B | 0.22% | |
| 61 | GBYSANGAMO THERAPEUTICS INC | 2,748,300 | $8.6B | 0.19% | |
| 62 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,028,200 | $7.6B | 0.16% | |
| 63 | —KINNATE BIOPHARMA INC | 1,212,700 | $7.4B | 0.16% | |
| 64 | ANTXAN2 THERAPEUTICS INC | 743,600 | $7.1B | 0.15% | |
| 65 | IPSCCENTURY THERAPEUTICS INC | 1,303,600 | $6.7B | 0.14% | |
| 66 | —MEDICUS SCIENCES ACQUISITION | 520,000 | $5.2B | 0.11% | |
| 67 | GRPHGRAPHITE BIO INC | 1,575,000 | $5.2B | 0.11% | |
| 68 | —ARYA SCIENCES ACQU CORP IV | 500,000 | $5.0B | 0.11% | |
| 69 | —PANACEA ACQUISITION CORP II | 500,000 | $5.0B | 0.11% | |
| 70 | EPIEURESSA PHARMA INC | 1,855,400 | $4.7B | 0.10% | |
| 71 | —HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.0B | 0.09% | |
| 72 | SYRSSYROS PHARMACEUTICALS INC | 900,000 | $3.2B | 0.07% | |
| 73 | CYTCYTEIR THERAPEUTICS INC | 1,795,800 | $3.0B | 0.06% | |
| 74 | —CAREMAX INC | 755,329 | $2.8B | 0.06% | |
| 75 | —SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $2.0B | 0.04% | |
| 76 | —SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $2.0B | 0.04% | |
| 77 | SCYXSCYNEXIS INC | 1,140,600 | $1.8B | 0.04% | |
| 78 | HYPRHYPERFINE INC | 1,503,754 | $1.3B | 0.03% | |
| 79 | FATEFATE THERAPEUTICS INC | 104,653 | $1.1B | 0.02% | |
| 80 | ZLABZAI LAB LTD | 31,309 | $961.2M | 0.02% | |
| 81 | COLLCOLLEGIUM PHARMACEUTICAL INC | 37,898 | $879.2M | 0.02% | |
| 82 | ACIUAC IMMUNE SA | 325,400 | $663.8M | 0.01% | |
| 83 | —REUNION NEUROSCIENCE INC | 560,300 | $504.3M | 0.01% | |
| 84 | NUVB/WSNUVATION BIO INC | 99,999 | $14.4M | 0.00% | |
| 85 | —MEDICUS SCIENCES ACQUISITION | 57,770 | $5.2M | 0.00% |